-
Cyprus-based company operates a fully digital telemedicine platform, enabling remote consultations and digital prescriptions
-
Launched in 2024, the platform has served approximately 20,000 patients and processed over 6,500 prescriptions per month
-
Focused on deep process optimization to ensure scalability before launching targeted marketing campaigns, including Facebook advertising and affiliate marketing, and continues to implement new features to enhance user experience
-
Profitable business with margins exceeding 60%, a current revenue run rate of ~€140,000 per month, and a forecasted €1.5M by year-end, reflecting ~20% annual growth
-
Income is generated through patient appointment bookings, marketing services for pharmacies, partnerships with leading producers, and white-label product offerings.
-
Operates efficiently with ~12 staff/freelancers, leveraging front-end and back-end freelance specialists
-
Automated workflows reduce doctor consultation time by 90%, and the platform supports white-label functionality for rapid B2B expansion
-
Projected annual growth of 15–20% is driven by rising patient demand and recent liberalization of the German cannabis market
-
Seeking full sale and includes the going concern business, intellectual property, brand, patient database, and software codebase